title: Aripiprazole treatment of risperidone-induced hyperprolactinemia.
authors: Jing Xu
authors: JX
authors: Chen
authors: Yun Ai
authors: YA
authors: Su
authors: Shao Li
authors: SL
authors: Wang
authors: Qing Tao
authors: QT
authors: Bian
authors: Yan Hong
authors: YH
authors: Liu
authors: Ning
authors: N
authors: Wang
authors: Fu De
authors: FD
authors: Yang
authors: Colin
authors: C
authors: Haile
authors: Thomas R
authors: TR
authors: Kosten
authors: Xiang Yang
authors: XY
authors: Zhang
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D000068180:Aripiprazole; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011446:Prospective Studies; D015363:Quinolones / Q000627:therapeutic use*; D018967:Risperidone / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole; D018967:Risperidone